Full-Time

Staff Mechanical Engineer

Confirmed live in the last 24 hours

10x Genomics

10x Genomics

1,001-5,000 employees

Biotechnology tools for genomic research

Compensation Overview

$176.8k - $239.2kAnnually

+ Equity Grants + Annual Bonus

Expert

Pleasanton, CA, USA

Category
Design Engineering
Mechanical Maintenance and Reliability Engineering
Mechanical Engineering
Required Skills
SolidWorks
Requirements
  • BS/MS/Ph.D. in mechanical engineering with a minimum of 10 years relevant industry experience
  • Systematic aptitude with an emphasis on theoretical fundamentals
  • High Proficiency using software like 3D CAD to design mechanisms; SolidWorks preferred (3D design & surfacing), Finite Element Analysis (such as SolidWorks Simulation)
  • Project Management experience a plus
  • Machining, casting, sheetmetal & high volume injection molding experience a plus
  • Comfortable in examining electrical assemblies and sensors
  • Comfortable with all phases of the product development lifecycle including design, implementation, debugging, verification, qualification, and transfer
  • Excellent communication and documentation skills
  • Comfortable operating machine shop equipment
  • Proven understanding of component selection criteria, and design for reliability and manufacturability
  • Process development and assembly instructions
  • Experience with instrumentation in medical devices, biotechnology, motion control, automation or robotics
Responsibilities
  • Lead the design, development and implementation of technical solutions for complex projects, involving multiple domains. Participate in project planning and scheduling.
  • Participate in all phases of product development, including requirements definition, concept generation, detailed design, manufacturing process development, assembly, integration, verification, and validation testing.
  • Manage a large scope of mechanical design work including possible partnership with external partners.
  • Create new product architectures for next generation instruments
  • Conceptualize and examine complex electro mechanical assemblies, create theoretical models, conducts empirical confirmation & performs computer assisted simulations
  • Design and Develop mechanical parts and assemblies, with careful consideration for mechanical design, kinematics, materials (plastics & metals) and stress analysis
  • Create product functional and design specifications. Performs DFMEA on parts that are designed
  • Working collaboratively within multi-disciplinary teams to define requirements for new and current designs
  • Study and test product designs
  • Identify and research new vendors/processes to manufacture components
  • Assist in initial design of fixtures and processes to assemble components
  • Create new product assembly instructions
  • Develop and perform component verification testing and product validation testing
  • Support production of final product by troubleshooting process and component problems
  • Provide engineering support to Manufacturing, NPI, and Service to facilitate transfer of designs.
  • Document, prepare and review patent submissions
  • Assess field reliability data and improve existing product designs as necessary
  • Shepherd projects through the design control process (design specification, design review, risk analysis, etc.), and support New Product Introduction personnel in initial builds (procurement, assembly, troubleshooting)
Desired Qualifications
  • Experience with at least two of the following areas: control systems, system integration, mass flow and thermodynamics, microfluidics systems, injection molding, optical systems
  • Proficient in SolidWorks and EPDM/PDMWorks
  • Experienced in generating mechanical drawings
  • Proficient with analysis methods (FEA and tolerance analysis)
  • Knowledge of and experience with electronic document control systems (ECO process)
  • Can independently identify design problems and come up with suggested solutions
  • Ability to work in a multi-disciplinary team including chemistry and molecular biology
  • Knowledge of a variety of manufacturing techniques and processes
  • Experience with injection molded part design
  • Experience operating machine tools
  • Excellent written and verbal communication skills in English
  • Ability to communicate in a clear, concise, personable manner
  • High energy and interest in working in a startup environment
  • Hands-on, can-do approach
  • Knowledge of software programming or electrical engineering design

10x Genomics provides tools and technologies for genomic research, focusing on single-cell analysis, spatial gene expression, and immune profiling. Their products enable researchers to analyze genetic information in detail, which is crucial for understanding complex biological systems and advancing personalized medicine. The company differentiates itself by offering high-quality laboratory equipment, consumables, and software solutions, along with ongoing support for clients in the life sciences sector. The goal of 10x Genomics is to empower researchers to explore the complexities of the human genome and drive advancements in medical research.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Pleasanton, California

Founded

2012

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing demand for spatial transcriptomics boosts 10x Genomics' market potential in cancer research.
  • Multi-omics approaches create opportunities for expanding 10x Genomics' product lines and services.
  • AI-driven data analysis tools enhance efficiency, complementing 10x Genomics' software solutions.

What critics are saying

  • Increased competition from emerging biotech companies may erode 10x Genomics' market share.
  • Ongoing patent disputes with companies like Parse Biosciences pose litigation risks.
  • Rapid technological advancements require continuous innovation to maintain 10x Genomics' competitive edge.

What makes 10x Genomics unique

  • 10x Genomics offers unique single-cell and spatial analysis tools for detailed genomic research.
  • Their robust patent portfolio protects innovative technologies from competitors like Parse Biosciences.
  • 10x Genomics' integrated solutions include instruments, consumables, and software for comprehensive genomic analysis.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Comprehensive health benefits

Generous time off

Parental leave

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Stock Titan
Mar 6th, 2025
Zimmer Biomet Names Kristen Cardillo as Senior Vice President, Chief Communications Officer

Cardillo joins from 10x Genomics, where she served as Vice President of Corporate Communications.

PR Newswire
Mar 3rd, 2025
10X Genomics Secures Injunction Against Parse Biosciences' Planned Atac Products

10x Genomics' ATAC-Seq patents found valid and infringedPLEASANTON, Calif., March 3, 2025 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG), a leader in single-cell and spatial biology, today provided an update on its patent litigation with Parse Biosciences. Through a consent agreement entered on February 25, 2025, in the United States District Court for the District of Delaware, Parse agreed - a week before trial was to start - to a worldwide permanent injunction that prevents it from making, using, selling or offering for sale its planned ATAC and ATAC-Multiome Single Cell products. As part of this consent agreement, Parse admitted that 10x's ATAC-seq patents are valid, enforceable and infringed by Parse's use of ATAC-seq methods and compositions."This development further validates the strength of our broad patent portfolio, which helps protect and preserve the world-class innovation engine at 10x," said Eric S. Whitaker, Chief Legal Officer of 10x Genomics. "We are pleased with this resolution on ATAC as we continue to defend the asserted Brenner patents on appeal."The company's litigation against Parse's gene expression products remains ongoing, with additional asserted patents under appeal. Following entry of the injunction, the trial scheduled for March 2025 concerning 10x's remaining patent infringement claims against Parse has been stayed pending those appeals.10x Genomics is committed to defending its intellectual property and investing in groundbreaking technologies that empower researchers worldwide.About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health

PR Newswire
Feb 23rd, 2025
10X Genomics Unveils Innovation Roadmap At Agbt General Meeting, Advancing Leadership In Large-Scale Single Cell And Spatial Analysis

New single cell and spatial innovations extend 10x Genomics' technology and performanceleadership across all three platformsPLEASANTON, Calif., Feb. 23, 2025 /PRNewswire/ -- At the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced a series of new product innovations to solidify its position as the best partner for high-performance single cell research at scale. In addition, the company unveiled a robust new product roadmap for its Visium and Xenium portfolios, extending its performance and technology leadership in the rapidly growing field of spatial biology."After a record year of innovation, we continue to push the boundaries of what's possible in single cell and spatial biology, taking on the hardest challenges so researchers can make the biggest impact," said Ben Hindson, Co-Founder and Chief Scientific Officer of 10x Genomics. "Our 2025 roadmap will once again raise the bar for the field and enable researchers to tackle bigger questions, analyze more samples and extract deeper insights from their data."10x Genomics will host a workshop at AGBT today, Sunday, February 23, at 1 p.m. ET to share the latest data and development directions across its three platforms

PR Newswire
Feb 18th, 2025
10X Genomics To Participate In The 45Th Annual Td Cowen Health Care Conference

PLEASANTON, Calif., Feb. 18, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate in a fireside chat at the TD Cowen 45th Annual Health Care Conference on Tuesday, March 4, at 11:10 a.m. Eastern Time.Interested parties may access a live webcast of the fireside chat on the "Investors" section of the company's website at: https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 45 days after the event.About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables, and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology

PR Newswire
Jan 12th, 2025
10X Genomics Announces Preliminary Select Fourth Quarter And Full Year 2024 Results

FY 2024 revenue of ~$611 million and Q4 2024 revenue of ~$165 million, representing 9% growth sequentiallyPLEASANTON, Calif., Jan. 12, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced preliminary, unaudited select results for the fourth quarter and full year ended December 31, 2024.Preliminary, Unaudited Select Fourth Quarter 2024 Financial ResultsRevenue of approximately $165.0 million for the three months ended December 31, 2024 , representing 9% growth sequentially and a 10% decrease as compared to the corresponding prior year period.for the three months ended , representing 9% growth sequentially and a 10% decrease as compared to the corresponding prior year period. Instruments revenue of approximately $24.4 million , representing 28% growth sequentially and a 37% decrease as compared to the corresponding prior year period. Instruments revenue consists of approximately $10.9 million of Chromium instruments revenue and $13.4 million of Spatial instruments revenue., representing 28% growth sequentially and a 37% decrease as compared to the corresponding prior year period. Instruments revenue consists of approximately of Chromium instruments revenue and of Spatial instruments revenue